Evidence map›Paper›PMID 42381872›Full record

ArticleFrontiers in endocrinology2026

A nomogram as a predictive tool for lymph node metastasis in papillary thyroid carcinoma.

Yimeng Liu, Tianxiang Liu, Yi Long, Xin Wang, Mei Tao, Kejia Xu, Xing Wan, Jimin Zhao, Guangwei Xu, Jie Gao and 3 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yimeng Liu *Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, China.
Tianxiang Liu *School of Medicine, Nankai University, Tianjin, China.
Yi LongSchool of Medicine, Nankai University, Tianjin, China.
Xin WangTianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, China.
Mei TaoTianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, China.
Kejia XuSchool of Medicine, Nankai University, Tianjin, China.
Xing WanTianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, China.
Jimin ZhaoTianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, China.
Guangwei XuTianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, China.
Jie GaoTianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, China.
Yongjun PiaoSchool of Medicine, Nankai University, Tianjin, China.
Xuan QinTianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, China.
Xiangqian ZhengTianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymph node metastasis is the most prevalent form of spread in thyroid cancer, with surgical intervention and prophylactic cervical lymph node dissection being the standard treatments. However, there remains a lack of effective methods for predicting lymph node metastasis in clinical practice. The study enrolled patients who were admitted to the Department of Thyroid and Neck Oncology at Tianjin Medical University Cancer Hospital between October 2021 and March 2022, as well as from February to April 2024. Variables collected included basic patient information, laboratory tests, and pathological data. Additionally, we focused on investigating the impact of emotional problems on lymph node metastasis. Subsequently, variable selection was performed using Least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression analyses. A nomogram was then constructed for predicting lymph node metastasis, with model performance assessed using calibration curves, decision curves and other methods. In this study, a total of 484 cases were ultimately included, and the variables were screened using LASSO regression. Subsequently, nine variables were utilized to construct a nomogram. For model training purposes, 85% of the data was randomly selected as the training set and the prediction efficiency was verified using ROC curve analysis. The AUC index for both the training set (0.8045) and verification set (0.8146) were obtained along with calibration curve and decision curve plots. This study developed a nomogram to predict lymph node metastasis in papillary thyroid cancer. This model demonstrates exceptional discrimination and calibration, providing invaluable assistance for clinical decision-making processes.

Indexed as

Lymphatic MetastasisNomogramsThyroid Cancer, PapillaryThyroid NeoplasmsAdultFemaleHumansLymph NodesMaleMiddle AgedPrognosisROC Curvelymph node metastasisnomogramPHQ-9predictionthyroid cancer

Identifiers

PMID42381872
PMCPMC13314451

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.